Discover 1,089 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,089
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Location: West Jordan UT, Provo UT, Meridian ID, Las Vegas NV,
Sponsor: Amgen
Sex: All
Age: 45 - 70+
Code: NCT07037433
Phase 3, Recruiting
Active & Responsive
VTP-1000 in Adults With Celiac Disease
for
Celiac Disease
Location: West Jordan UT, Colorado Springs CO, Los Angeles CA,
Sponsor: Barinthus Biotherapeutics
Sex: All
Age: 18 - 70
Code: NCT06310291
Early Phase 1, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Sandy City UT, Englewood CO, Aurora CO, Las Vegas NV,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
for
Alopecia Areata
Location: South Jordan UT, Santa Clarita CA, Fremont CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 60
Code: NCT07533006
Phase 2, Recruiting
Active & Responsive
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
for
Knee Cartilage Defects
Location: Salt Lake City UT, Steamboat Springs CO, Parker CO,
Sponsor: Medipost, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07339111
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
for
Myopia, Astigmatism
Location: Draper UT
Sponsor: Hoopes Vision
Sex: All
Age: 22 - 50
Code: NCT07201298
Recruiting
Active & Responsive
RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Draper UT, Orem UT, Albuquerque NM, Gilbert AZ,
Sponsor: Reunion Neuroscience Inc
Sex: All
Age: 18 - 70+
Code: NCT07489651
Phase 2, Recruiting
Active & Responsive
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
for
Post Traumatic Stress Disorder
Location: Draper UT, Orem UT, Evergreen CO, Phoenix AZ,
Sponsor: Transcend Therapeutics
Sex: All
Age: 18+
Code: NCT07456696
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
for
Treatment Resistant Depression
Location: Draper UT, Denver CO, Glendale CA, Santa Monica CA,
Sponsor: atai Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06524830
Phase 2, Recruiting
Active & Responsive
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
for
Major Depressive Disorder
Location: Draper UT, Orem UT, Denver CO, Las Vegas NV, Orange CA,
Sponsor: Definium Therapeutics US, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07592689
Phase 3, Recruiting
Active & Responsive
Motiva Implants® Post-Approval Study
for
Breast Implant
Location: South Jordan UT, Denver CO, Camp Pendleton CA,
Sponsor: Motiva USA LLC
Sex: Female
Age: 22+
Code: NCT06938399
Recruiting
Active & Responsive
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
for
Capsular Contracture Associated With Breast Implant,
Location: Draper UT, Lone Tree CO, Reno NV, Scottsdale AZ,
Sponsor: C. R. Bard
Sex: Female
Age: 22 - 70
Code: NCT05945329
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for
Overweight, Obesity
Location: Ogden UT, Sandy City UT, Aurora CO, Albuquerque NM,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07282600
Phase 3, Recruiting
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event